Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew D Levin

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Handbook of Clinical Neurology|November 23, 2019
Headache in the elderlyRobert G Kaniecki, Andrew D Levin
The Journal of Biological Chemistry|October 4, 2002
Phosphorylation-induced conformational changes in a mitogen-activated protein kinase substrate. Implications for tyrosine hydroxylase activationCollin M Stultz, Andrew D Levin, Elazer R Edelman
Proceedings of the National Academy of Sciences of the United States of America|June 16, 2004
Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxelAndrew D Levin, Neda Vukmirovic, Chao-Wei Hwang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 18, 2005
Local and systemic drug competition in drug-eluting stent tissue deposition propertiesAndrew D Levin, Michael Jonas, Chao-Wei Hwang, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 17, 2007
Transition from bare metal to drug eluting stenting in contemporary US practice: effect on incidence and predictors of clinically driven target lesion revascularizationMichael Jonas, Frederic S Resnic, Andrew D Levin, et al.
Circulation|March 30, 2005
Thrombosis modulates arterial drug distribution for drug-eluting stentsChao-Wei Hwang, Andrew D Levin, Michael Jonas, et al.
The Lancet. Infectious Diseases|June 30, 2012
Optimising the manufacture, formulation, and dose of antiretroviral drugs for more cost-efficient delivery in resource-limited settings: a consensus statementKeith W Crawford, David H Brown Ripin, Andrew D Levin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 23, 2011
Optimizing antiretroviral product selection: a sample approach to improving patient outcomes, saving money, and scaling-up health services in developing countriesCarolyn D Amole, Catherine Brisebois, Shaffiq Essajee, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Handbook of Clinical Neurology|November 23, 2019
Headache in the elderlyRobert G Kaniecki, Andrew D Levin
The Journal of Biological Chemistry|October 4, 2002
Phosphorylation-induced conformational changes in a mitogen-activated protein kinase substrate. Implications for tyrosine hydroxylase activationCollin M Stultz, Andrew D Levin, Elazer R Edelman
Proceedings of the National Academy of Sciences of the United States of America|June 16, 2004
Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxelAndrew D Levin, Neda Vukmirovic, Chao-Wei Hwang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 18, 2005
Local and systemic drug competition in drug-eluting stent tissue deposition propertiesAndrew D Levin, Michael Jonas, Chao-Wei Hwang, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 17, 2007
Transition from bare metal to drug eluting stenting in contemporary US practice: effect on incidence and predictors of clinically driven target lesion revascularizationMichael Jonas, Frederic S Resnic, Andrew D Levin, et al.
Circulation|March 30, 2005
Thrombosis modulates arterial drug distribution for drug-eluting stentsChao-Wei Hwang, Andrew D Levin, Michael Jonas, et al.
The Lancet. Infectious Diseases|June 30, 2012
Optimising the manufacture, formulation, and dose of antiretroviral drugs for more cost-efficient delivery in resource-limited settings: a consensus statementKeith W Crawford, David H Brown Ripin, Andrew D Levin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 23, 2011
Optimizing antiretroviral product selection: a sample approach to improving patient outcomes, saving money, and scaling-up health services in developing countriesCarolyn D Amole, Catherine Brisebois, Shaffiq Essajee, et al.
Pageof 1